Mfn2 regulates mitochondria-associated ER membranes to affect PCOS oocyte development

Area of Science:

• Reproductive Biology
• Cellular Biology
• Endocrinology

Background:

• Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting female reproduction.
• Oocyte quality is crucial for successful fertilization and embryonic development in PCOS.
• Mitochondrial dysfunction is increasingly recognized as a contributor to PCOS pathophysiology.

Purpose of the Study:

• To investigate the role of mitofusin 2 (Mfn2) in PCOS.
• To determine the impact of Mfn2 on oocyte development in a PCOS context.
• To explore the relationship between Mfn2, mitochondria-associated ER membranes (MAMs), and mitochondrial function in PCOS.

Main Methods:

• Confirmation of PCOS mouse model pathology using hematoxylin-eosin staining and immunohistochemistry.
• Quantification of Mfn2 and mitochondrial protein expression via qRT-PCR and Western blot.
• Assessment of mitochondrial quantity using Mito-Tracker staining and MAM structure via transmission electron microscopy.

Main Results:

• Mfn2 expression was significantly downregulated in PCOS oocytes and granulosa cells.
• Downregulation of Mfn2 led to reduced mitochondrial quantity and disrupted MAM structure.
• Overexpression of Mfn2 reversed these detrimental effects, improving mitochondrial quantity and MAM integrity.

Conclusions:

• Mfn2 plays a critical role in PCOS oocyte development.
• Mfn2 influences oocyte quality by regulating MAM structure and stability.
• Mfn2 may represent a therapeutic target for improving reproductive outcomes in PCOS.